» Articles » PMID: 33678168

Hypertension is Associated with Osteoporosis: a Case-control Study in Chinese Postmenopausal Women

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2021 Mar 8
PMID 33678168
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteoporosis and cardiovascular disease (CVD) are age-related diseases. It is reported that patients with CVD have a higher risk of bone loss. This retrospective study sought to reveal the association between osteoporosis and CVD in Chinese women. Although epidemiological evidence has indicated a relationship between the two, clinical data in southeast China are lacking.

Methods: In total, 2873 participants completed the baseline survey from January 2007 to October 2019, and 2039 were included in this retrospective study. We divided all subjects into an osteoporosis group and a non-osteoporosis group based on their bone mineral density (BMD). Dual-energy X-ray absorptiometry (DXA) was used to examine BMD. The general information came from the questionnaire survey. Cardiovascular diseases were defined by asking participants at the first visit and checking relevant medical records if they had suffered from hypertension, coronary heart disease, or cerebral infarction.

Results: According to the criterion, the osteoporosis group had 678 subjects, and the non-osteoporosis group had 1361 subjects. Subjects in the osteoporosis group had a significantly higher prevalence of hypertension and coronary heart disease. Besides, the proportion of subjects who drank tea and drank milk were relatively higher in the osteoporosis group. The odds ratio (OR) for suffering from osteoporosis was high if the patients had hypertension.

Conclusions: This study indicated that Chinese postmenopausal women with osteoporosis had a higher prevalence of hypertension. Hypertension was significantly associated with osteoporosis.

Citing Articles

Fracture Risk Assessment in Metabolic Syndrome in Terms of Secondary Osteoporosis Potential. A Narrative Review.

Armutcu F, McCloskey E Calcif Tissue Int. 2025; 116(1):41.

PMID: 39979438 PMC: 11842537. DOI: 10.1007/s00223-025-01341-5.


A simple and user-friendly machine learning model to detect osteoporosis in health examination populations in Southern Taiwan.

Huang W, Chen I, Yu H, Chen C, Wu F, Hsu C Bone Rep. 2025; 24:101826.

PMID: 39896106 PMC: 11783436. DOI: 10.1016/j.bonr.2025.101826.


SNPs in GPCR Genes and Impaired Osteogenic Potency in Osteoporotic Patient Lines-Based Study.

Sopova J, Krasnova O, Vasilieva G, Zhuk A, Lesnyak O, Karelkin V Int J Mol Sci. 2025; 25(24.

PMID: 39769358 PMC: 11677449. DOI: 10.3390/ijms252413594.


Unraveling the Mechanism of Impaired Osteogenic Differentiation in Osteoporosis: Insights from Gene Polymorphism.

Krasnova O, Sopova J, Kovaleva A, Semenova P, Zhuk A, Smirnova D Cells. 2025; 13(24.

PMID: 39768200 PMC: 11674950. DOI: 10.3390/cells13242110.


The low bone mass density in adults with hypertension: A meta-analysis.

Gao Y, Tian X, Zhang G, Yu J, Zhang L J Orthop. 2024; 63:70-76.

PMID: 39564087 PMC: 11570227. DOI: 10.1016/j.jor.2024.10.041.


References
1.
Cauley J . Estrogen and bone health in men and women. Steroids. 2015; 99(Pt A):11-5. DOI: 10.1016/j.steroids.2014.12.010. View

2.
Sacco R, Adams R, Albers G, Alberts M, Benavente O, Furie K . Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the.... Circulation. 2006; 113(10):e409-49. View

3.
Hofbauer L, Schoppet M . Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004; 292(4):490-5. DOI: 10.1001/jama.292.4.490. View

4.
Pfeilschifter J, Koditz R, Pfohl M, Schatz H . Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002; 23(1):90-119. DOI: 10.1210/edrv.23.1.0456. View

5.
Covic A, Vervloet M, Massy Z, Urena Torres P, Goldsmith D, Brandenburg V . Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. Lancet Diabetes Endocrinol. 2017; 6(4):319-331. DOI: 10.1016/S2213-8587(17)30310-8. View